Dr. Bassem Saleh new Chief Executive Officer of TFS The Board of Directors of TFS, a leading mid-size CRO providing clinical development solutions to biopharmaceutical companies, appointed Dr. Bassem Saleh…
Read More
On September 19th, TFS hosted a seminar in Medicon Village starting a much needed discussion about the changes impacting the biopharmaceutical industry. Representatives from the biotech, academic and investor community…
On January 14, 2019, it was announced that Ratos acquires remaining shares in TFS. This acquisition is a natural next step of the change in ownership structure that started two…